News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Jim Geller’s insights about Symposium Advances in the Treatment and Biology of Malignant Rhabdoid Tumour – SIOP
Jul 13, 2024, 12:05

Jim Geller’s insights about Symposium Advances in the Treatment and Biology of Malignant Rhabdoid Tumour – SIOP

“Join Jim Geller at the SIOP congress and learn valuable insights about his session on ‘Symposium Advances in the Treatment and Biology of Malignant Rhabdoid Tumour’.

Early Bird Registration Deadline: July 17, 2024.  .

Register now.”

Video attached to the post.
Source:

cancer International Society of Paediatric Oncology Jim Geller Malignant Rhabdoid Tumour OncoDaily Oncology SIOP SIOP congress Symposium Advances valuable insights
Special Coverage
Blog
Nov 15, 2024, 21:44
Karen Humphreys won the Advocate of the Year from the Florida Society of Clinical Oncology - UF Health Cancer Center
Blog
Nov 15, 2024, 21:37
Margaret Foti: AACR Special Conference on Liquid Biopsy
Blog
Nov 15, 2024, 21:26
Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy
Blog
Nov 15, 2024, 21:21
Adjuvant immunotherapy in patients with resected GEJ cancer with high risk for recurrence
Blog
Nov 15, 2024, 21:09
Miriam Knoll: An in-person lung tumor board with Nagashree Seetharamu
Insight
Nov 15, 2024, 21:05
Get Ready for ESTRO2025 Pre-Meeting Courses
Insight
Nov 15, 2024, 21:03
Explore the latest in oncology at ESMOASIA24
Insight
Nov 15, 2024, 21:02
Robin Zon: Debate day 2 of COSA
Blog
Nov 15, 2024, 20:28
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment
Blog
Nov 15, 2024, 19:31
What is proton beam therapy and how does it work - Atrium Health
Blog
Nov 15, 2024, 17:47
Nico Gagelmann: Current status and Future directions for CAR-T Therapy
Insight
Nov 15, 2024, 17:45
Osteopontin as a therapeutic target in Breast Cancer recurrence